Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future.

Revkin JH, Shear CL, Pouleur HG, Ryder SW, Orloff DG.

Pharmacol Rev. 2007 Mar;59(1):40-53. Review.

PMID:
17329547
2.

Early versus delayed enalapril in patients with left ventricular systolic dysfunction: impact on morbidity and mortality 15 years after the SOLVD trial.

Ahn SA, Jong P, Yusuf S, Bangdiwala SI, Pouleur HG, Rousseau MF.

J Am Coll Cardiol. 2006 May 2;47(9):1904-5. Epub 2006 Apr 17. No abstract available.

3.

Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.

Van Beneden R, Gurné O, Selvais PL, Ahn SA, Robert AR, Ketelslegers JM, Pouleur HG, Rousseau MF.

J Card Fail. 2004 Dec;10(6):490-5.

PMID:
15599839
4.

Clinical overview of irbesartan: a new angiotensin II receptor antagonist.

Pouleur HG.

Am J Hypertens. 1997 Dec;10(12 Pt 2):318S-324S. Review.

PMID:
9438776
5.

Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.

Pouleur HG, Konstam MA, Udelson JE, Rousseau MF.

J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):43A-48A.

Supplemental Content

Loading ...
Support Center